Key result
Correction updates generative AI usage statement in prior rheumatic mitral valve repair manuscript.
Why the study?
Broad adoption of mitral valve repair for rheumatic disease is limited by high early failure rates, prompting evaluation of perioperative predictors of early MR recurrence.
Answers are grounded in this paper and cite their sources.
In patients undergoing rheumatic mitral valve repair, preoperative echocardiographic parameters were not independent predictors of early moderate-to-severe mitral regurgitation recurrence in multivariate analysis.
Rheumatic heart disease represents a leading cause of cardiovascular morbidity and mortality worldwide. In 2019, the estimated national prevalence of rheumatic valvular disease in China was 9,073,096 cases (95% uncertainty interval: 7,393,886-10,994,319) (1). Rheumatic mitral valve disease typically presents with predominant MR during the acute phase (2). Over time, pathological involvement progresses from the commissures to involve the entire mitral valve apparatus-including leafiets, chordae tendineae, and papillary muscles-with severe structural alterations in subvalvular components and leafiet tissue (3)(4)(5) correlating strongly with progressive functional deterioration. Leafiet thickening and diminished tissue elasticity impair dynamic coaptation surface adjustment (6), while chordal thickening and calcification induce restrictive tethering, preventing adequate leafiet apposition-thereby establishing the anatomical substrate of rheumatic MR. Although mitral valve repair offers well-documented advantages such as preservation of native valve physiology (1,7) and elimination of lifelong anticoagulation requirements (8), its broader adoption remains limited by persistently high rates of early failure and reoperation (9). Consequently, mitral valve replacement (MVR) accounts for over 95% of surgical interventions for rheumatic mitral disease globally. This study retrospectively enrolled patients who underwent open-chest mitral valve repair for rheumatic etiology at our institution, aiming to identify independent perioperative predictors of non-minimal MR (defined as ≥ mild MR) within 14 days postoperatively-thereby informing strategies to enhance procedural durability and long-term success.This study was approved by the Ethics Committee of Shanghai Fourth People's Hospital, Tongji University School of Medicine (approval date: January 2, 2025; approval number: 2024245-002). As a retrospective observational study utilizing exclusively deidentified, anonymized clinical data with no capacity for subject re-identification, this research qualifies for waiver of informed consent in accordance with the institutional policies of the Ethics Committee. Patients diagnosed with rheumatic mitral valve disease at Shanghai Fourth People's Hospital Affiliated to Tongji University between March 17, 2023, andDecember 15, 2025, who underwent open mitral valve repair surgery at our institution, were enrolled in this study. To minimize interinstitutional variability in echocardiographic assessment and ensure data consistency, only patients who completed postoperative follow-up echocardiography at our center were included. A total of 164 patients with complete follow-up records were identified (baseline characteristics are summarized in Table 1).CJA, color jet area; VCW, vena contracta width; MR, mitral regurgitation; MVOA, mitral valve orifice area; MVR, mitral valve replacementFollowing standard induction of cardiopulmonary bypass, the left atrium was opened to allow direct visualization of the mitral valve apparatus and assessment of valvular pathology. The SCORE "4-step technique" was systematically performed as follows: (1) removal of fibrous plaques at the commissural regions; (2) approximation of the leafiets to evaluate the natural alignment of the commissures and determine the appropriate extent of commissurotomy; (3) division of fused commissures; and (4) release of the fused subvalvular apparatus, including incision of conjoined chordae tendineae and papillary muscles. Subsequently, additional thinning of the thickened anterior and posterior mitral leafiets was performed to restore leafiet mobility and fiexibility. Valve competence was then assessed through saline distension testing (water test) and sizing with a valvuloplasty gauge, followed by implantation of an appropriately sized mitral annuloplasty ring. The atriotomy was closed in layers, completing the mitral valve repair procedure. After successful weaning from cardiopulmonary bypass and restoration of spontaneous cardiac rhythm, intraoperative transesophageal echocardiography (TEE) was performed to evaluate the immediate results. In cases where non-minimal MR (moderate or severe) regurgitation was detected, re-intervention was undertaken. When residual regurgitation was mild or less, the surgical procedure was considered satisfactory and the operation was concluded.Currently, the evaluation of MR remains primarily based on transthoracic echocardiography. According to established guidelines, MR is classified as mild when the following criteria are met-regardless of etiology: a small central jet, preserved leafiet morphology, VCW < 0.3 cm, absence of proximal fiow convergence, and an A-wave-dominant mitral infiow patternthereby obviating the need for further quantitative assessment (10,11). A small central jet is defined as a CJA < 4 cm2 (12). The mitral valve orifice area was measured in the parasternal long-axis view at the level of the mitral valve and in the left ventricular short-axis view; transvalvular pressure gradients were assessed using continuous-wave Doppler in the apical fourchamber, two-chamber, or three-chamber views; VCW was measured in the apical four-chamber view; and CJA was quantified in the apical four-chamber, two-chamber, or threechamber views during mid-systole. Current clinical practice guidelines (13) consistently recommend conservative management for patients with mild or asymptomatic (i.e., grade I or trace) MR, given their significantly more favorable longterm prognosis compared with those exhibiting moderate or severe MR. Repeat surgical intervention is not indicated in the absence of disease progression; reoperation is reserved exclusively for cases in which MR advances to meet established surgical indications-such as worsening symptoms, left ventricular dysfunction, or echocardiographic evidence of progressive remodeling. Consequently, the persistence of mild or no/minimal MR within the early postoperative period serves as a validated imaging biomarker refiecting successful anatomical and functional correction of the underlying valvular pathology.Mild MR was diagnosed according to established echocardiographic criteria-including CJA and VCW), and additional quantitative and qualitative parameters-and patients were stratified into two group accordingly. The mild MR group comprised patients who maintained mild or less regurgitation within 14 days postoperatively (none/trivial/mild) (hereafter, this cohort is designated Group M), whereas the non-minimal MR/ severe group included those who developed moderate or greater mitral regurgitation during the same period (moderate/severe) (hereafter, this cohort is designated Group S). Predefined variables analyzed included preoperative MVOA, preoperative mitral CJA, history of percutaneous mitral balloon valvuloplasty, intraoperative mitral and tricuspid annuloplasty ring sizes, concurrent stripping of thickened leafiets, concomitant aortic valve repair, maze procedure, and left atrial appendage resection.Data collection and entry were performed using EpiData 3.1 software, and data cleaning along with database management was carried out in Microsoft Excel. Statistical analyses were conducted using SPSS 29.0 software. Non-normally distributed continuous variables were summarized as medians and interquartile ranges (IQRs), while categorical variables were expressed as frequencies and proportions. Comparisons of normally distributed continuous variables between groups were performed using the independent samples Student's t-test, whereas the Mann-Whitney U test was applied for nonnormally distributed variables. Categorical variables were compared using the chi-square test or Fisher's exact test, as appropriate. Univariate binary logistic regression analysis was used to evaluate the association between individual variables and the outcome of interest; variables with statistical significance in univariate analysis were further included in multivariate logistic regression models to identify independent predictors. A twosided P value < 0.05 was considered statistically significant.(1) A total of 164 patients were enrolled in this study. Of these, 11 (6.71%) constituted the Group S and 153 (93.29%) Group M. Baseline characteristics were well balanced between groups: Group S comprised 1 male, with a median age of 53.0 years; In contrast, Group M included 35 males, with a median age of 44.0 years. No baseline variable differed significantly between groups (Table 1). ( 2) Statistically significant between-group differences were observed in preoperative CJA (median: 11.85 cm2 vs. 4.20 cm2, P = 0.01) and preoperative MVOA (median: 1.60 cm2 vs. 1.10 cm2, P = 0.01). No other baseline characteristics differed significantly between groups (all P > 0.05) (Table 2). ( 3) Univariate binary logistic regression identified intraoperative simultaneous stripping of thickened valve leafiets (OR = 4.41, 95% CI: 1.03-18.82, P = 0.045), preoperative CJA (OR = 1.17, 95% CI: 1.04-1.31, P = 0.01), and preoperative MVOA (OR = 3.33, 95% CI: 1.09-10.19, P = 0.04) as significant predictors of moderate/severe MR recurrence within 14 days postoperatively. No other variables demonstrated statistically significant associations (all P > 0.05). (4) In the multivariate logistic regression model adjusting for intraoperative simultaneous stripping of thickened mitral leafiets, preoperative CJA remained significantly associated with recurrence of moderate/severe MR within 14 days postoperatively (OR = 1.16; 95% CI: 1.03-1.30; P = 0.02). However, this association attenuated and became statistically non-significant after additional adjustment for preoperative MVOA (OR = 1.13; 95% CI: 0.97-1.31; P = 0.12). In the final model, no variable was independently associated with the outcome (all P > 0.05). Preoperative mitral valve CJA and MVOA were correlated (r = [0.445], P < 0.001), but not collinear (Tol. = 0.98, VIF = 1.02). Preoperative mitral valve CJA and concurrent stripping of thickened leafiets were correlated (r = [__0.218], P = 0.03), but not collinear (Tol. = 0.98, VIF = 1.02) (Tables 3456).This study investigated predictors of moderate/severe MR recurrence within 14 days following rheumatic mitral valve repair and identified three key findings: (1) Despite baseline comparability between the two patient groups, our results diverged from prior evidence regarding several procedural (18,19), however, due to two fundamental technical limitations inherent to current surgical practice-namely. Firstly, during intraoperative resection of thickened mitral leafiets, the rough band on the ventricular surface that anchors the chordae tendineae (20) remains inaccessible for surgical modulation. This region exhibits marked surface very rough and may disrupt physiological force transmission along the chordal apparatus, predisposing to chordal rupture. Consequently, coexisting zones of preserved fiexibility and pathological rigidity-emerge within a single leafiet. Leafiet fiexibility is essential for uniform stress distribution across its surface (21); loss of this property in locally fibrotic or calcified segments compromises biomechanical homeostasis, leading to focal stress concentration, iatrogenic chordal injury, and subsequent secondary MR. At the same time, the anatomical substrate essential for coaptation reserve is localized predominantly in the region subjacent to the coaptation line.; if mobility in this critical zone remains impaired, global coaptation improvement will be inherently limited. Collectively, the "leafiet stripping" strategy is limited by the inherent constraints of current surgical technology.; thus, the recurrence of MR will be manifested by the CJA. Second, histopathological analysis revealed that the boundary between the rheumatic mitral valve leafiet lesion tissue and the adjacent normal tissue was indistinct (22). Consequently, intraoperative visual assessment cannot reliably delineate the precise boundary for safe dissection (30), and current instrumentation lacks the selectivity to isolate pathological matrix without compromising native collagen architecture. Forced or overly aggressive stripping frequently results in microtears within the lamina fibrosa or endothelial denudation-both of which compromise local tensile strength. Following surgical intervention, elevated systolic ventricular pressure induces heterogeneous strain distribution across the mitral leafiet due to regional variations in tissue compliance-specifically, the juxtaposition of pliable and stiffened segments-resulting in disproportionate bulging of mechanically compromised zones, pulling the relatively rigid segment immediately below the coaptation line toward the annulus and paradoxically widening the coaptation gap. While thinning it, the area of the valve orifice is simultaneously artificially enlarged, compromises the orifice's intrinsic compensatory capacity (a narrowed mitral orifice reduces the coaptation distance, thereby facilitating earlier leafiet apposition during systole-a intrinsic biomechanical compensation mechanism),-a plausible structural contributor to early post-repair MR. The recurrence of MR will be manifested by the CJA too. The clinical effect in patients with not very severe thickening of the leafiets lmay fall short of the theoretical objective of "fully restoring global leafiet mobility", particular surgical caution is warranted in these patients intraoperatively. Finally, it is plausible that the myocardial and valvular remodeling triggered by leafiet thinning unfolds over a timeframe extending well beyond 14 days; definitive assessment of its long-term functional consequences therefore necessitates extended follow-up beyond the early postoperative window. Should future advances overcome the current technical limitations -and extend longitudinal follow-up beyond the completion of cardiac remodeling-the leafiet-thinning intervention may robustly manifest its therapeutic potential, including enhanced valve compliance, and favorable modulation of ventricular remodeling.The degree of structural stiffness in rheumatic mitral valves is a key determinant of postoperative MR recurrence (18). Prior evidence indicates that preoperative mitral stenosis compromises the durability and functional outcomes of rheumatic mitral valve repair (23); critically, this refiects an underlying, irreversible fibrocalcific stiffening of the leafiets and subvalvular apparatus. Our findings corroborate this pathophysiological link. Yet, a major unmet need remains: the lack of a comprehensive, objective, and clinically applicable metric to quantify mitral valve structural stiffness. The widely adopted Wilkins score-designed exclusively for patient selection and procedural outcome assessment in percutaneous balloon mitral valvuloplasty for mitral stenosis (24)lacks sensitivity to regurgitant hemodynamics and is therefore unsuitable for rheumatic patients with predominant MR, mixed disease. In contrast, this study demonstrates that the CJA serves as a robust, reproducible, and quantifiable imaging-derived surrogate for intrinsic valve stiffness. Importantly, CJA can predict perioperative risk and informs tailored surgical decision-making. It should be emphasized that the CJA itself is not a pathogenic factor. Its clinical risk correlation stems from the irreversible stiffness of the valve structure, which it represents.To systematically define the clinical decision-support value of the CJA, this study stratifies rheumatic mitral valve disease into three pathophysiologically distinct stages-termed the *MR progression phase*, the *MR attenuation phase*, and the *MR re enlargement phase*-based on longitudinal hemodynamic and structural evolution. The MR progression phase corresponds to early rheumatic involvement, characterized predominantly by MR. Progressive MR lead to increasing MVOA, which further compromises coaptation surface area and amplifies regurgitant volume (25). Clinically, both CJA and MVOA increase in parallel during this phase. Crucially, valvular structural stiffness remains minimal; consequently, repair success rates are exceptionally high, surgeons with documented experience in rheumatic mitral reconstruction are qualified to perform valve repair surgery. As disease advances, patients enter the MR attenuation phase. Here, CJA declines-not due to milder Greater lesion complexity is strongly associated with an increased incidence of intraoperative residual structural abnormalities. Over time, these uncorrected elements progressively impair the reconstructed valvular apparatus, disrupting coaptation geometry and fiow dynamics. This leads to composite valvular dysfunction and confers a substantial risk of late recurrence of either stenosis or regurgitation (28,29). To optimize long-term outcomes, intraoperative assessment must be comprehensive and systematic -evaluating all components of the mitral apparatus. Achieving this objective demands exceptional surgical expertise and deep, rheumatic-specific clinical experience. Consequently, mitral valve repair should be performed exclusively by high-volume surgical teams with sustained, dedicated expertise in rheumatic mitral reconstruction. In contrast, for surgeons lacking such proficiency, mitral valve replacement-not attempted repair-represents the evidence-based, patient-centered standard of care. Findings from the three-phase analysis collectively demonstrate that CJA and MVOA capture distinct, complementary manifestations of valvular structural stiffness-CJA refiects the hemodynamic functional consequences of valvular structural stiffness, whereas MVOA captures its anatomical-morphological correlates-these two parameters are mechanistically distinct and non-redundant. Future work should validate these staging criteria in large, multicenter prospective cohorts to rigorously establish the causal association between CJA-defined structural stiffness and the risk of moderate/severe MR recurrence within 14 days postoperatively -thereby enabling precise quantification of its predictive performance and real-world clinical utility.(1) This study has a relatively limited sample size, with only 164 patients enrolled, classifying it as a single-center, small-sample investigation. While this may constrain the statistical power and generalizability of the findings, future expansion of the cohort through prolonged follow-up and inclusion of additional patients is anticipated. Furthermore, the limitation can be addressed by adopting a multicenter collaborative design in subsequent studies to enhance external validity. (2) This study is a recently conducted clinical observational study. While perioperative confounding factors-including those related to surgical technique, timing, and early postoperative management-were explicitly accounted for during the initial 14-day postoperative period, the overall follow-up duration remains limited. This constraint may attenuate the statistical power and limit both the internal validity of associations identified and the external validity (i.e., generalizability) of the findings. To strengthen analytical rigor, we applied stringent variable selection criteria and excluded patients with substantial missing clinical or echocardiographic data, thereby mitigating potential biases-including information bias and residual compromise Future will extended longitudinal follow-up to robustly long-term clinical outcomes, disease and the durability of therapeutic (3) A key limitation the of patients in this cohort underwent concomitant tricuspid valve annuloplasty during mitral valve surgery. As a postoperative tricuspid regurgitation was or of continuous-wave Doppler of the tricuspid regurgitant jet on transthoracic echocardiography. This constraint the and generalizability of hemodynamic assessment in the study. To future should hemodynamic heart quantitative and more of (4) that while mitral valve remodeling is the of disease progression in this CJA serves only as an for irreversible fibrocalcific Its as a quantitative metric for MR inherent are to and potential systematic current criteria for mild or MR are echocardiographic findings. In our quantitative MR missing VCW primarily due to their inherently in well-documented echocardiographic data parameters were therefore excluded from statistical The is to and rigorously validate a in established imaging and functional mitral valve structural significantly elevated CJA, when by a significantly MVOA, may rheumatic involvement and structural of both the mitral valve leafiets and subvalvular apparatus. substantial technical complexity to mitral valve repair and are associated with an elevated risk of early repair Consequently, such cases should be exclusively at with documented expertise in rheumatic mitral
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied rheumatic mitral valve repair. This article is a correction to update the generative AI usage statement in a previously published manuscript regarding rheumatic mitral valve repair.
Synapse has enriched 10 related papers. Consider them for comparative context: